Showing results (321-330 of 630) with videos related to

Sort By:
Pageof 63
The British Journal of Dermatology|September 7, 2020
Characteristics and impacts of itch in children with inflammatory skin disordersM M Fang, C J Nowinski, J Lai, et al.
American Journal of Clinical Dermatology|October 7, 2023
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1Eric L Simpson, Andrew Blauvelt, Jonathan I Silverberg, et al.
Dermatology and Therapy|September 25, 2023
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical TrialsHannah Penton, Sayeli Jayade, Santhani Selveindran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 15, 2017
Phenotypical Differences of Childhood- and Adult-Onset Atopic DermatitisJonathan I Silverberg, Paras P Vakharia, Rishi Chopra, et al.
The Journal of Investigative Dermatology|October 20, 2019
Development, Validation, and Interpretation of the PROMIS Itch Questionnaire: A Patient-Reported Outcome Measure for the Quality of Life Impact of ItchJonathan I Silverberg, Jin-Shei Lai, Robert W Kantor, et al.
Acta Dermato-Venereologica|April 8, 2022
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic DermatitisAndreas Wollenberg, Danielle Marcoux, Jonathan I Silverberg, et al.
Contact Dermatitis|May 16, 2025
Burden of Pain and Use of Analgesics in Patients With Chronic Hand Eczema-Findings From the Danish Skin CohortJeanette Halskou Haugaard, Johan Sieborg, Emma Guttman-Yassky, et al.
Scientific Reports|April 17, 2024
Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysisStella P Hartono, Sheena Chatrath, Ozge N Aktas, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2019
A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessmentWenhui Wei, Eric Ghorayeb, Michael Andria, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2018
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAbAndreas Wollenberg, Michael D Howell, Emma Guttman-Yassky, et al.
Pageof 63